GMV The Future, page-513

dear all,

The past week has been pretty disappointing to say the least. Sitting at all time lows never feels very good for current shareholders. That being said, where to from here? As Gylco points out is our choice if we sell, buy more or hold and put in the bottom draw.

I personally will be holding for now, looking to average down only if the price drops below 10c. But I'm
not sure if will get there.

Over the last few days I have engaged in a number of brief email exchanges with yacov. IMO he's disappointed and hurting like the rest of us and so he should be. On the other hand IMO he's beyond frustrated with approval process in China. So IMO and for what it's worth you can make you mind up in regards to the following:

IMO the company is in early early discussions regarding an Australian distributor for the Prizma. Whilst not a key market nor a large market, having the product available via JB Hi Fi, Chemist Warehouse or Telstra stores will enable factory production and create product credibility.

IMO the US IDTF business is moving in the right direction. There is just quite a lag between signing providers to then getting doctors to refer patients to GMV to then receiving funds. I'm not sure investors realised this. Bottom line is the infrastructure is there to scale up significantly and quickly.

IMO we will see more detailed shareholder communication. And maybe something more regular than once a qtr.

IMO I'm not sure Yacov will buy on market at these levels. IMO the offer of 2m shares during the week at 16c was to tempt him. It's a double edged sword. He buys and some people see that as a sign of confidence. But it could entice a huge wave of selling into this one and only significant buyer.

IMO there is no doubt Yacov will continue to fund this going forward. Did anyone else notice that $500k worth of convertible notes were redeemed during the qtr?

The UK business is definitely the most positive thing GMV has going for it. IMO it has c$3m USD worth of revenue that will be signed very soon. But it's the patch I'm most excited about. It's about to be commercially rolled out for the first time!

I have had discussions on US based forums regarding the Nasdaq IPO. I didn't get any direct feedback from anyone that attended the roadshow. But the investors that did respond were very excited about company, the sector, its products and acknowledged the issues are very typical for start up companies.

So what price do people put on this business? Mr ASX currently has $60m. At 10c we start to drift below $40m. With $8.2m AUD coming from the US ITDF business and another $4.4m AUD to be signed in the UK. So $12.8m with a market cap of $60m or 4.6x. A
brand new approved factory in China. Approvals in TGA, CE and FDA. Infrastructure in the US and UK to scale up the business quickly. First sales of the patch any day.

Forget China for now and MOUs completely. The current business can more than justify the current valuation.